Skip to main content
LEAP THERAPEUTICS, INC. logo

LEAP THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LPTX ISIN · US52187K2006 LEI · 549300T31SMMJ2DDLI13 US Manufacturing
Open in API
Filings indexed 584 across all filing types
Latest filing 2018-03-16 Share Issue/Capital Cha…
Country US United States of America
Listing US LPTX

About LEAP THERAPEUTICS, INC.

https://www.leaptx.com/

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer. Its most advanced clinical candidate, DKN-01 (sirexatamab), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, being developed for patients with esophagogastric, gynecologic, and colorectal cancers. The company's pipeline also includes FL-301, a monoclonal antibody targeting Claudin18.2 for gastric and pancreatic cancer, and FL-501, a preclinical antibody targeting the growth and differentiation factor 15 (GDF-15) protein.

Recent filings

Filing Released Lang Actions
S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as equity incentive plans. It includes details about the securities to be registered, the equity incentive plan, and signatures of company officers and directors. This type of filing is related to share issuance under employee plans and is not a financial report, earnings release, or management discussion. It is specifically about registering shares for issuance under an equity incentive plan, which falls under announcements regarding share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the registration statement itself, not just an announcement or a certification.
2018-03-16 English
DEF 14A
Proxy Solicitation & Information Statement
2018-03-16 English
S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC by Leap Therapeutics, Inc. It is a registration statement under the Securities Act of 1933 for the offering of securities including common stock, preferred stock, debt securities, and warrants. The document includes a prospectus and details about the securities to be registered and offered, including risk factors, plan of distribution, and legal matters. This type of filing is related to capital raising and financing activities by the company. It is not an annual report, earnings release, or management discussion, but rather a regulatory filing for securities registration and offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement of a report, so it is not RPA or RNS. Confidence is high given the clear identification of Form S-3 and registration statement content.
2018-03-02 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 23, 2018, by Leap Therapeutics, Inc. It announces the company's financial results for the fourth quarter and year ended December 31, 2017. The text states that the full press release is furnished as an exhibit to this Form 8-K. The document itself is relatively short (4018 characters) and primarily serves as an announcement of the earnings results rather than containing detailed financial statements or analysis. According to the rules, initial announcements of quarterly or periodical financial results with key highlights only are classified as Earnings Release (ER). This document fits that description as it announces the results and includes a press release but does not contain the full detailed report itself.
2018-02-23 English
10-K
Annual Report FY 2017
2018-02-23 English
SC 13D/A
Major Shareholding Notification
2018-02-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.